<p>富士胶卷控股公司（OTCMKTS:FUJIY - 获取免费报告）在周五交易前股价跳空下跌。该股此前收于 11.10 美元，但开盘价为 10.68 美元。富士胶卷的最后交易价格为 11.02 美元，成交量为 1,277 股。</p>
<h2>富士胶卷股价下跌 1.4%</h2>
<p>该股市值为 272.4 亿美元，市盈率为 8.36，市盈增长比率为 1.81，贝塔系数为 0.75。公司的流动比率为 1.38，速动比率为 0.87，债务股本比率为 0.16。该公司的 50 日移动平均线为 11.17 美元，200 日移动平均线为 11.25 美元。</p>
<p>富士胶卷（OTCMKTS:FUJIY - 获取免费报告）最近在 11 月 6 日（星期四）发布了季度财报。该科技公司报告本季度每股收益（EPS）为 0.75 美元，超出市场普遍预期的 0.17 美元，超出幅度为 0.58 美元。富士胶卷的股本回报率为 7.89%，净利润率为 8.31%。该公司本季度的收入为 53.3 亿美元，而市场普遍预期为 53.1 亿美元。整体来看，股票研究分析师预测富士胶卷控股公司本年度将发布 0.66 美元的每股收益。</p>
<h2>关于富士胶卷</h2>
<p>（获取免费报告）</p>
<p>富士胶卷控股公司在全球范围内开发、制造、销售和服务成像、医疗保健、材料和商业创新解决方案。公司的医疗保健部门提供产品和服务，如医疗设备、生物医学合同开发和制造组织、制药、再生医学以及在预防、诊断和治疗领域的化妆品和补充剂。</p>
<h2>相关文章</h2>
<ul>
<li>我们更看好的五只股票比富士胶卷更具吸引力</li>
<li>风险承受能力并非一刀切</li>
<li>Chewy 股票刚刚发出 2026 年的重大买入信号</li>
<li>什么是二次公开募股？投资者需要知道什么</li>
<li>尽管人工智能需求激增，博通在财报后仍下滑</li>
<li>哪些华尔街分析师最准确？</li>
<li>高通被称为人工智能失败者——那它为何在反弹？</li>
</ul>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在富士胶卷吗？</h2>
<p>在考虑富士胶卷之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前买入……而富士胶卷并不在名单上。</p>
<p>虽然富士胶卷目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

富士(ADR)

<p>富士 (ADR) 的股价出现下跌，开盘价为 10.68 美元，前一交易日收盘价为 11.10 美元，最后交易价为 11.02 美元。尽管季度每股收益为 0.75 美元超出预期，分析师仍维持 “持有” 评级，认为存在更好的投资选择。该股票的市值为 272.4 亿美元，市盈率为 8.36</p>

<p>Fujifilm Holdings Corp. (OTCMKTS:FUJIY - Get Free Report)'s stock price gapped down prior to trading on Friday . The stock had previously closed at $11.10, but opened at $10.68. Fujifilm shares last traded at $11.02, with a volume of 1,277 shares changing hands.</p>
<div class="lb-trans"><p>富士胶卷控股公司（OTCMKTS:FUJIY - 获取免费报告）在周五交易前股价跳空下跌。该股此前收于 11.10 美元，但开盘价为 10.68 美元。富士胶卷的最后交易价格为 11.02 美元，成交量为 1,277 股。</p>
</div><h2>Fujifilm Stock Down 1.4%</h2>
<div class="lb-trans"><h2>富士胶卷股价下跌 1.4%</h2>
</div><p>The stock has a market cap of $27.24 billion, a P/E ratio of 8.36, a P/E/G ratio of 1.81 and a beta of 0.75. The company has a current ratio of 1.38, a quick ratio of 0.87 and a debt-to-equity ratio of 0.16. The firm's fifty day moving average is $11.17 and its 200 day moving average is $11.25.</p>
<div class="lb-trans"><p>该股市值为 272.4 亿美元，市盈率为 8.36，市盈增长比率为 1.81，贝塔系数为 0.75。公司的流动比率为 1.38，速动比率为 0.87，债务股本比率为 0.16。该公司的 50 日移动平均线为 11.17 美元，200 日移动平均线为 11.25 美元。</p>
</div><p>Fujifilm (OTCMKTS:FUJIY - Get Free Report) last issued its quarterly earnings results on Thursday, November 6th. The technology company reported $0.75 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.17 by $0.58. Fujifilm had a return on equity of 7.89% and a net margin of 8.31%.The company had revenue of $5.33 billion for the quarter, compared to the consensus estimate of $5.31 billion. As a group, equities research analysts forecast that Fujifilm Holdings Corp. will post 0.66 EPS for the current year.</p>
<div class="lb-trans"><p>富士胶卷（OTCMKTS:FUJIY - 获取免费报告）最近在 11 月 6 日（星期四）发布了季度财报。该科技公司报告本季度每股收益（EPS）为 0.75 美元，超出市场普遍预期的 0.17 美元，超出幅度为 0.58 美元。富士胶卷的股本回报率为 7.89%，净利润率为 8.31%。该公司本季度的收入为 53.3 亿美元，而市场普遍预期为 53.1 亿美元。整体来看，股票研究分析师预测富士胶卷控股公司本年度将发布 0.66 美元的每股收益。</p>
</div><h2>About Fujifilm</h2>
<div class="lb-trans"><h2>关于富士胶卷</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>FUJIFILM Holdings Corporation develops, manufactures, sells, and services imaging, healthcare, materials, and business innovation solutions worldwide. The company's Healthcare segment provides products and services, such as medical devices, biomedical contract development and manufacturing organization, pharmaceutical, regenerative medicine, and cosmetics and supplements in the areas of prevention, diagnosis, and treatment.</p>
<div class="lb-trans"><p>富士胶卷控股公司在全球范围内开发、制造、销售和服务成像、医疗保健、材料和商业创新解决方案。公司的医疗保健部门提供产品和服务，如医疗设备、生物医学合同开发和制造组织、制药、再生医学以及在预防、诊断和治疗领域的化妆品和补充剂。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>相关文章</h2>
</div><ul>
<li>Five stocks we like better than Fujifilm</li>
<li>With Risk Tolerance, One Size Does Not Fit All</li>
<li>Chewy Stock Just Flashed a Major Buy Signal for 2026</li>
<li>What is a Secondary Public Offering? What Investors Need to Know</li>
<li>Broadcom Slips Post-Earnings Even as AI Demand Goes Parabolic</li>
<li>Which Wall Street Analysts are the Most Accurate?</li>
<li>Qualcomm Just Got Called an AI Loser—So Why Is It Rallying?</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票比富士胶卷更具吸引力</li>
<li>风险承受能力并非一刀切</li>
<li>Chewy 股票刚刚发出 2026 年的重大买入信号</li>
<li>什么是二次公开募股？投资者需要知道什么</li>
<li>尽管人工智能需求激增，博通在财报后仍下滑</li>
<li>哪些华尔街分析师最准确？</li>
<li>高通被称为人工智能失败者——那它为何在反弹？</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Fujifilm Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在富士胶卷吗？</h2>
</div><p>Before you consider Fujifilm, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑富士胶卷之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Fujifilm wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前买入……而富士胶卷并不在名单上。</p>
</div><p>While Fujifilm currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然富士胶卷目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

富士 (OTCMKTS:FUJIY) 股价跳空下跌 - 你是否应该卖出？